Psoriasis, psoriatic arthritis research makes headway at GRAPPA meetingAugust 10, 2017Psoriatic ArthritisPsoriasis
Study finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017PsoriasisPsoriatic Arthritis
Alopecia may be permanent in one in four pediatric HSCT patientsAugust 2, 2017PediatricsHair & NailsPsoriasis
First interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017PsoriasisPsoriatic Arthritis
Children with psoriasis face multitude of comorbiditiesJuly 15, 2017PsoriasisPediatricsPsoriatic Arthritis
First IL-23 blocker, guselkumab, earns FDA approval for psoriasisJuly 13, 2017PsoriasisPsoriatic Arthritis
Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic ArthritisPsoriasis
TWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitisJune 28, 2017Autoimmune DiseasesPsoriasisAtopic Dermatitis
Experts endorse routine screening for pediatric psoriasis comorbiditiesMay 30, 2017PsoriasisPediatricsPsoriatic Arthritis
Infliximab biosimilar noninferior to originator in IBD – NOR-SWITCHMay 23, 2017Psoriatic ArthritisPsoriasis